Tectonic Therapeutic announced advanced Phase 2 trials for pulmonary hypertension and Phase 1a testing for a rare bleeding disorder.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tectonic Therapeutic announced advanced Phase 2 trials for pulmonary hypertension and Phase 1a testing for a rare bleeding disorder.